Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade
These three companies know something about beating the market over many years.
DexCom(DXCM)
Nasdaq Global Select
DXCM
$390.26
-$15.32
-3.8%
Price as of March 11, 2022, 4:00 p.m. ET
View Interactive DXCM Charts
A medical device company focused on the design, development and commercialization of continuous glucose monitoring systems for people with diabetes.
Interactive Chart
Compare DXCM Stock to Peers
| Symbol | Last Price | Market Cap | % Δ 1 Yr | % Δ 5 Yr |
|---|---|---|---|---|
|
DXCM
DexCom
|
$390.26 | $38B | 6.4% | 402.9% |
|
ISRG |
$273.69 | $98B | 12.2% | 235.6% |
|
TDOC |
$54.61 | $9B | -72.5% | 158.2% |
|
UNH |
$482.87 | $454B | 39.1% | 205.7% |
|
VEEV |
$174.44 | $27B | -33.2% | 272.5% |
News & Analysis: DexCom
The Fool has written over 200 articles on DexCom.
Up 700%, DexCom Stock Still Has Tons of Room To Run
The market for its products is huge.
Bull vs. Bear: DexCom Stock
Why are investors bullish on DexCom?
DexCom (DXCM) Q4 2021 Earnings Call Transcript
DXCM earnings call for the period ending December 31, 2021.
2 Unstoppable Growth Stocks to Buy in 2022 and Beyond
Both companies still have miles of growth left ahead.
Got $5,000? 2 Top Growth Stocks to Buy and Hold for Decades
These companies have at least one thing in common: leadership in industries with solid tailwinds.
2 Unstoppable Growth Stocks to Buy and Hold Forever
These companies have already handsomely rewarded shareholders, but it's not over yet.
Here's Why Investors Should Consider DexCom Stock
This is one of the fastest-growing healthcare stocks right now.
My Take: 4 Strong Growth Stocks To Buy This Week
If these companies' growth prospects were good enough before the omicron-fueled rout, they're even better now.
3 Reasons This Stock Could 10X in 10 Years
This healthcare company isn't done beating the market.
